Argan (AGX) Stock Forecast, Price Target & Predictions
AGX Stock Forecast
Argan stock forecast is as follows: an average price target of $85.00 (represents a -6.70% downside from AGX’s last price of $91.10) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
AGX Price Target
The average price target for Argan (AGX) is $85.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $85.00 to $85.00. This represents a potential -6.70% downside from AGX's last price of $91.10.
AGX Analyst Ratings
According to 1 Wall Street analysts, Argan's rating consensus is 'Buy'. The analyst rating breakdown for AGX stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Argan Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jun 07, 2024 | Robert Brown | Lake Street | $85.00 | $75.95 | 11.92% | -6.70% |
| Jun 07, 2024 | Rob Brown | Loop Capital Markets | $85.00 | $76.36 | 11.31% | -6.70% |
| Apr 12, 2024 | Rob Brown | Loop Capital Markets | $70.00 | $54.80 | 27.74% | -23.16% |
The latest Argan stock forecast, released on Jun 07, 2024 by Robert Brown from Lake Street, set a price target of $85.00, which represents a 11.92% increase from the stock price at the time of the forecast ($75.95), and a -6.70% decrease from AGX last price ($91.10).
Argan Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 3 |
| Avg Price Target | - | - | $80.00 |
| Last Closing Price | $91.10 | $91.10 | $91.10 |
| Upside/Downside | -100.00% | -100.00% | -12.18% |
In the current month, the average price target of Argan stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Argan's last price of $91.10. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jun 07, 2024 | Lake Street | Buy | Buy | Hold |
| Apr 12, 2024 | Lake Street | Buy | Buy | Hold |
Argan's last stock rating was published by Lake Street on Jun 07, 2024. The company gave AGX a "Buy" rating, the same as its previous rate.
Argan Financial Forecast
Argan Revenue Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | May 20 | Jan 20 | Oct 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $163.75M | $141.35M | - | $118.78M | $117.88M | $118.11M | $100.28M | $125.57M | $124.45M | $133.01M | - | $117.23M | $127.33M | $87.49M | - | $67.99M | $58.41M |
| Avg Forecast | $249.70M | $253.10M | $241.30M | $231.00M | $233.50M | $242.00M | $230.90M | $202.00M | $207.05M | $225.60M | $191.05M | $134.75M | $162.05M | $160.85M | $140.55M | $113.45M | $122.45M | $131.75M | $118.00M | $106.05M | $120.85M | $129.70M | $134.20M | $118.35M | $137.15M | $117.00M | $84.55M | $65.70M | $81.80M | $50.25M |
| High Forecast | $263.78M | $267.37M | $254.91M | $244.03M | $246.67M | $255.65M | $243.92M | $213.39M | $208.95M | $249.30M | $201.82M | $142.35M | $171.19M | $169.92M | $148.48M | $119.85M | $129.35M | $139.18M | $124.14M | $107.22M | $120.85M | $129.70M | $134.20M | $118.35M | $137.15M | $117.00M | $84.55M | $65.70M | $81.80M | $50.25M |
| Low Forecast | $235.62M | $238.83M | $227.69M | $217.97M | $220.33M | $228.35M | $217.88M | $190.61M | $205.15M | $201.90M | $180.28M | $127.15M | $152.91M | $151.78M | $132.62M | $107.05M | $115.55M | $124.32M | $111.86M | $104.88M | $120.85M | $129.70M | $134.20M | $118.35M | $137.15M | $117.00M | $84.55M | $65.70M | $81.80M | $50.25M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | - | - | - | 2 | 2 | 1 | 1 | - | 1 | - | - | - | - | - | - | - | - | - | - | 7 | 7 | 7 | 7 | 7 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.01% | - | 0.97% | 0.89% | 1.00% | 0.95% | 1.04% | 0.96% | 0.99% | - | 0.85% | 1.09% | 1.03% | - | 0.83% | 1.16% |
Argan's average Quarter revenue forecast for Jan 24 based on 0 analysts is $162.05M, with a low forecast of $152.91M, and a high forecast of $171.19M. AGX's average Quarter revenue forecast represents a -1.04% decrease compared to the company's last Quarter revenue of $163.75M (Oct 23).
Argan EBITDA Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | May 20 | Jan 20 | Oct 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | - | - | - | 2 | 2 | 1 | 1 | - | 1 | - | - | - | - | - | - | - | - | - | - | 7 | 7 | 7 | 7 | 7 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $7.86M | $13.24M | - | $9.56M | $9.54M | $13.40M | $10.14M | $7.72M | $15.59M | $18.41M | - | $13.02M | $12.11M | $7.69M | - | $-3.12M | $-4.97M |
| Avg Forecast | $7.18M | $7.28M | $6.94M | $6.64M | $6.72M | $6.96M | $6.64M | $5.81M | $5.95M | $6.49M | $5.49M | $3.88M | $4.66M | $4.63M | $4.04M | $3.26M | $3.52M | $29.56M | $3.39M | $3.05M | $10.93M | $4.30M | $7.16M | $3.92M | $4.54M | $31.62M | $-5.58M | $2.18M | $-22.57M | $-3.22M |
| High Forecast | $7.59M | $7.69M | $7.33M | $7.02M | $7.09M | $7.35M | $7.01M | $6.14M | $6.01M | $7.17M | $5.80M | $4.09M | $4.92M | $4.89M | $4.27M | $3.45M | $3.72M | $35.48M | $3.57M | $3.08M | $13.11M | $4.30M | $8.60M | $3.92M | $4.54M | $37.94M | $-4.46M | $2.18M | $-18.06M | $-2.57M |
| Low Forecast | $6.78M | $6.87M | $6.55M | $6.27M | $6.34M | $6.57M | $6.27M | $5.48M | $5.90M | $5.81M | $5.18M | $3.66M | $4.40M | $4.36M | $3.81M | $3.08M | $3.32M | $23.65M | $3.22M | $3.02M | $8.74M | $4.30M | $5.73M | $3.92M | $4.54M | $25.29M | $-6.69M | $2.18M | $-27.08M | $-3.86M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.70% | 3.28% | - | 2.72% | 0.32% | 3.95% | 3.32% | 0.71% | 3.63% | 2.57% | - | 2.86% | 0.38% | -1.38% | - | 0.14% | 1.55% |
0 analysts predict AGX's average Quarter EBITDA for Jan 24 to be $4.66M, with a high of $4.92M and a low of $4.40M. This is -40.71% lower than Argan's previous annual EBITDA (Oct 23) of $7.86M.
Argan Net Income Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | May 20 | Jan 20 | Oct 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | - | - | - | 2 | 2 | 1 | 1 | - | 1 | - | - | - | - | - | - | - | - | - | - | 7 | 7 | 7 | 7 | 7 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $5.46M | $12.77M | - | $13.63M | $7.76M | $4.22M | $7.49M | $-323.00K | $12.39M | $12.87M | - | $9.55M | $9.45M | $5.61M | - | $-12.23M | $-4.56M |
| Avg Forecast | $21.10M | $21.79M | $20.40M | $19.15M | $19.85M | $20.40M | $18.74M | $15.68M | $15.41M | $17.49M | $13.46M | $7.22M | $10.41M | $11.94M | $10.34M | $3.89M | $9.85M | $24.54M | $2.99M | $4.47M | $10.08M | $6.98M | $6.50M | $4.68M | $6.37M | $26.25M | $-1.05M | $-1.08M | $-41.95M | $909.21K |
| High Forecast | $22.64M | $23.39M | $21.90M | $20.56M | $21.30M | $21.90M | $20.11M | $16.83M | $15.55M | $17.77M | $14.45M | $7.75M | $11.17M | $12.81M | $11.10M | $4.17M | $10.58M | $29.45M | $3.19M | $4.54M | $12.09M | $6.98M | $7.79M | $4.68M | $6.37M | $31.50M | $-839.30K | $-1.08M | $-33.56M | $1.09M |
| Low Forecast | $19.55M | $20.19M | $18.91M | $17.75M | $18.39M | $18.91M | $17.36M | $14.53M | $15.27M | $17.21M | $12.48M | $6.69M | $9.65M | $11.06M | $9.58M | $3.60M | $9.13M | $19.64M | $2.78M | $4.41M | $8.06M | $6.98M | $5.20M | $4.68M | $6.37M | $21.00M | $-1.26M | $-1.08M | $-50.34M | $727.37K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.46% | 1.23% | - | 1.38% | 0.32% | 1.41% | 1.67% | -0.03% | 1.77% | 1.98% | - | 1.50% | 0.36% | -5.35% | - | 0.29% | -5.02% |
Argan's average Quarter net income forecast for Jan 24 is $10.41M, with a range of $9.65M to $11.17M. AGX's average Quarter net income forecast represents a 90.52% increase compared to the company's last Quarter net income of $5.46M (Oct 23).
Argan SG&A Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | May 20 | Jan 20 | Oct 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | - | - | - | 2 | 2 | 1 | 1 | - | 1 | - | - | - | - | - | - | - | - | - | - | 7 | 7 | 7 | 7 | 7 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $11.38M | $10.50M | - | $10.47M | $12.67M | $10.98M | $10.57M | $15.51M | $11.59M | $10.33M | - | $10.21M | $9.40M | $9.09M | - | $12.36M | $12.13M |
| Avg Forecast | $27.43M | $27.80M | $26.50M | $25.37M | $25.65M | $26.58M | $25.36M | $22.19M | $22.74M | $24.78M | $20.98M | $14.80M | $17.80M | $17.67M | $15.44M | $12.46M | $13.45M | $39.75M | $12.96M | $11.65M | $9.42M | $14.52M | $5.97M | $13.25M | $15.35M | $42.52M | $14.22M | $7.35M | $74.27M | $7.91M |
| High Forecast | $28.97M | $29.37M | $28.00M | $26.80M | $27.09M | $28.08M | $26.79M | $23.44M | $22.95M | $27.38M | $22.17M | $15.63M | $18.80M | $18.66M | $16.31M | $13.16M | $14.21M | $47.70M | $13.63M | $11.78M | $11.31M | $14.52M | $7.16M | $13.25M | $15.35M | $51.02M | $17.07M | $7.35M | $89.12M | $9.49M |
| Low Forecast | $25.88M | $26.23M | $25.01M | $23.94M | $24.20M | $25.08M | $23.93M | $20.94M | $22.53M | $22.18M | $19.80M | $13.97M | $16.80M | $16.67M | $14.57M | $11.76M | $12.69M | $31.80M | $12.29M | $11.52M | $7.54M | $14.52M | $4.77M | $13.25M | $15.35M | $34.01M | $11.38M | $7.35M | $59.41M | $6.33M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.64% | 0.68% | - | 0.78% | 0.32% | 0.85% | 0.91% | 1.65% | 0.80% | 1.73% | - | 0.67% | 0.22% | 0.64% | - | 0.17% | 1.53% |
Argan's average Quarter SG&A projection for Jan 24 is $17.80M, based on 0 Wall Street analysts, with a range of $16.80M to $18.80M. The forecast indicates a 56.47% rise compared to AGX last annual SG&A of $11.38M (Oct 23).
Argan EPS Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | May 20 | Jan 20 | Oct 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | - | - | - | 2 | 2 | 1 | 1 | - | 1 | - | - | - | - | - | - | - | - | - | - | 7 | 7 | 7 | 7 | 7 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.41 | $0.95 | - | $1.01 | $0.56 | $0.30 | $0.50 | $-0.02 | $0.79 | $0.82 | - | $0.61 | $0.60 | $0.36 | - | $-0.78 | $-0.29 |
| Avg Forecast | $1.52 | $1.57 | $1.47 | $1.38 | $1.43 | $1.47 | $1.35 | $1.13 | $1.11 | $1.26 | $0.97 | $0.52 | $0.75 | $0.86 | $0.74 | $0.28 | $0.71 | $0.70 | $0.22 | $0.33 | $0.26 | $0.52 | $0.48 | $0.34 | $0.47 | $0.32 | $0.04 | $-0.08 | $-0.07 | $-0.10 |
| High Forecast | $1.63 | $1.69 | $1.58 | $1.48 | $1.53 | $1.58 | $1.45 | $1.21 | $1.12 | $1.28 | $1.04 | $0.56 | $0.80 | $0.92 | $0.80 | $0.30 | $0.76 | $0.76 | $0.23 | $0.33 | $0.26 | $0.52 | $0.48 | $0.34 | $0.47 | $0.32 | $0.04 | $-0.08 | $-0.07 | $-0.10 |
| Low Forecast | $1.41 | $1.45 | $1.36 | $1.28 | $1.33 | $1.36 | $1.25 | $1.05 | $1.10 | $1.24 | $0.90 | $0.48 | $0.70 | $0.80 | $0.69 | $0.26 | $0.66 | $0.65 | $0.21 | $0.33 | $0.26 | $0.52 | $0.48 | $0.34 | $0.47 | $0.32 | $0.04 | $-0.08 | $-0.07 | $-0.10 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.48% | 1.28% | - | 1.42% | 0.79% | 1.36% | 1.52% | -0.08% | 1.53% | 1.71% | - | 1.30% | 1.90% | 8.00% | - | 12.00% | 2.90% |
According to 0 Wall Street analysts, Argan's projected average Quarter EPS for Jan 24 is $0.75, with a low estimate of $0.70 and a high estimate of $0.80. This represents a 82.93% increase compared to AGX previous annual EPS of $0.41 (Oct 23).
Argan Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| AMRC | Ameresco | $34.28 | $58.14 | 69.60% | Buy |
| MYRG | MYR Group | $98.19 | $125.00 | 27.30% | Buy |
| BBCP | Concrete Pumping | $5.71 | $7.25 | 26.97% | Hold |
| APG | APi Group | $34.47 | $41.00 | 18.94% | Buy |
| ACA | Arcosa | $91.34 | $105.33 | 15.32% | Buy |
| TPC | Tutor Perini | $24.18 | $26.50 | 9.59% | Buy |
| BLD | TopBuild | $386.49 | $376.29 | -2.64% | Buy |
| ROAD | Construction Partners | $65.09 | $62.33 | -4.24% | Strong Buy |
| AGX | Argan | $91.10 | $85.00 | -6.70% | Buy |
| GVA | Granite Construction | $76.37 | $70.00 | -8.34% | - |
| PRIM | Primoris Services | $54.60 | $41.50 | -23.99% | Buy |
AGX Forecast FAQ
Is Argan a good buy?
Yes, according to 1 Wall Street analysts, Argan (AGX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of AGX's total ratings.
What is AGX's price target?
Argan (AGX) average price target is $85 with a range of $85 to $85, implying a -6.70% from its last price of $91.1. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Argan stock go up soon?
According to Wall Street analysts' prediction for AGX stock, the company can go down by -6.70% (from the last price of $91.1 to the average price target of $85), down by -6.70% based on the highest stock price target, and down by -6.70% based on the lowest stock price target.
Can Argan stock reach $140?
AGX's average twelve months analyst stock price target of $85 does not support the claim that Argan can reach $140 in the near future.
What are Argan's analysts' financial forecasts?
Argan's analysts financial forecasts for the fiscal year (Jan 2026) are as follows: average revenue is $908.4M (high $959.62M, low $857.18M), average EBITDA is $26.12M (high $27.6M, low $24.65M), average net income is $74.67M (high $80.15M, low $69.2M), average SG&A $99.77M (high $105.4M, low $94.15M), and average EPS is $5.38 (high $5.77, low $4.99). AGX's analysts financial forecasts for the fiscal year (Jan 2027) are as follows: average revenue is $975.1M (high $1.03B, low $920.12M), average EBITDA is $28.04M (high $29.62M, low $26.46M), average net income is $82.45M (high $88.49M, low $76.4M), average SG&A $107.1M (high $113.14M, low $101.06M), and average EPS is $5.94 (high $6.38, low $5.5).
Did the AGX's actual financial results beat the analysts' financial forecasts?
Based on Argan's last annual report (Jan 2023), the company's revenue was $455.04M, which missed the average analysts forecast of $478.25M by -4.85%. Apple's EBITDA was $41.67M, beating the average prediction of $39.53M by 5.42%. The company's net income was $33.1M, missing the average estimation of $41.86M by -20.92%. Apple's SG&A was $44.69M, missing the average forecast of $77.81M by -42.56%. Lastly, the company's EPS was $2.35, beating the average prediction of $1.97 by 19.59%. In terms of the last quarterly report (Oct 2023), Argan's revenue was $163.76M, beating the average analysts' forecast of $160.85M by 1.81%. The company's EBITDA was $7.86M, beating the average prediction of $4.63M by 69.92%. Argan's net income was $5.46M, missing the average estimation of $11.94M by -54.23%. The company's SG&A was $11.38M, missing the average forecast of $17.67M by -35.61%. Lastly, the company's EPS was $0.41, missing the average prediction of $0.86 by -52.33%